SCHEMBL29083948

SCHEMBL29083948

COc1cc(Nc2ncc(Br)c(Nc3ccccc3C(C)(C)O)n2)c(C)cc1N1CCC(OC)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 2/20 0.48
▸ LRRK2 Q5S007 2/20 0.48
▸ ULK1 O75385 2/20 0.46
▸ EGFR P00533 6/20 0.45
▸ ALK Q9UM73 4/20 0.44
▸ ZAP70 P43403 3/20 0.44
▸ IGF1R P08069 2/20 0.44
▸ PLK1 P53350 2/20 0.44
▸ CDC7 O00311 1/20 0.44
▸ PLK4 O00444 1/20 0.44
▸ CHEK1 O14757 1/20 0.44
▸ AURKA O14965 1/20 0.44
▸ DCLK1 O15075 1/20 0.44
▸ PDPK1 O15530 1/20 0.44
▸ DAPK3 O43293 1/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ PAK4 O96013 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29083976 0.90 LRRK2 (0.46) LRRK2ULK1EGFRALKIGF1R
SCHEMBL29084066 0.89 EGFR (0.55) MAP4K1LRRK2EGFRALKIGF1R
SCHEMBL29084072 0.81 EGFR (0.54) LRRK2EGFRALKIGF1RPLK1
SCHEMBL29084007 0.81 EGFR (0.51) LRRK2EGFRALKIGF1RPLK1
SCHEMBL29083952 0.81 PLK1 (0.52) EGFRPLK1CHEK1AURKAJAK2
SCHEMBL29084155 0.81 EGFR (0.56) EGFRALKIGF1RPLK1
SCHEMBL29084120 0.81 EGFR (0.64) MAP4K1EGFRALKIGF1RCHEK1
SCHEMBL29084107 0.80 EGFR (0.46) MAP4K1LRRK2EGFRALKCSF1R
SCHEMBL29083968 0.80 ALK (0.44) MAP4K1LRRK2EGFRALKIGF1R
SCHEMBL29084049 0.79 ULK1 (0.48) LRRK2ULK1EGFRALKZAP70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 — — CN claimed
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 — — CN disclosed
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO disclosed
Send feedback